Nadia Salem

Role: Executive Director Clinical Operations at Supernus Pharmaceuticals, Inc.
Location: Washington, DC, US
LinkedIn followers: 500 followers

View LinkedIn profile

About Nadia Salem

Senior pharmaceutical executive with 17+ years of experience in drug development with…

Experience

Executive Director Clinical Operations
Supernus Pharmaceuticals, Inc.
Apr 2022 — Present

Education

Università degli Studi di Perugia
Doctor of Pharmacy (PharmD), Pharmacy
The George Washington University
Master of Public Health (MPH), Public Health

Skills

Life Sciences
Ctms
CRO
Biotechnology
Gcp
Infectious Diseases
Vaccines
Lifesciences
Clinical Development
Clinical Trials
Neuroscience
Oncology
Patient Recruitment
Clinical Data Management
Therapeutic Areas
Edc
Drug Development
Pharmaceutical Industry
Ich-Gcp
Clinical Research

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
n•••••@supernus.com
Personal email
•••••@•••••.com
Direct dial
+12•••••••18

Unlock verified contacts

Free to start · No credit card required

Current company

Supernus Pharmaceuticals, Inc.

Pharmaceutical Manufacturing · 858 employees · Founded 2005 · Rockville, Maryland, United States

Supernus Pharmaceuticals, Inc. (the Company) is a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases. The Company's diverse neuroscience portfolio includes approved treatments for attention-deficit hyperactivity disorder (ADHD), dyskinesia in Parkinson's Disease (PD) patients receiving levodopa-based therapy, hypomobility in PD, epilepsy, migraine, cervical dystonia, and chronic sialorrhea. Supernus is developing a broad range of novel CNS product candidates including new potential treatments for epilepsy, depression, and other CNS disorders. Supernus Pharmaceuticals was incorporated in Delaware, commenced operations in 2005, and became publicly traded in 2012. Our principal executive offices are located in Rockville, Maryland. Our extensive expertise in product development has been built over the past 30 years: initially as a stand-alone development organization; then, as a United States (U.S.) subsidiary of Shire Plc (Shire, a subsidiary of Takeda Pharmaceutical Company Ltd.); then upon our acquisition of substantially all of the assets of Shire Laboratories, Inc. in 2005, as Supernus Pharmaceuticals. Recently, Supernus acquired the CNS portfolio from US WorldMeds (2020), Adamas Pharmaceuticals (2021) and Sage Therapeutics (2025) strengthening its position in CNS disorders and establishing a position in Women’s Health. To learn more about our products you can visit our product specific sites: http://www.qelbree.com http://www.onapgo.com http://www.gocovri.com http://www.zurzuvae.com http://www.trokendixr.com http://www.oxtellarxr.com http://www.apokyn.com http://www.myobloc.com http://www.xadago.com

supernus.com

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

About Nadia Salem

Experience

Executive Director Clinical Operations

Education

Università degli Studi di Perugia

The George Washington University

Skills

Find verified contacts for anyone on LinkedIn